Developing E-liquid Product Standards (Sweet Spot Study)

Last updated: March 21, 2025
Sponsor: Ohio State University Comprehensive Cancer Center
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Vaping study EC C

Vaping study EC A

Vaping study EC G

Clinical Study ID

NCT05864586
OSU-22253
NCI-2023-03206
  • Ages 21-50
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The Sweet Spot Study aims to evaluate the effect of e-liquids with nicotine varying in freebase (FB) levels and concentrations on the appeal of electronic cigarettes (ECs) in young adult EC users with minimal/no history of smoking and older adult smokers.

Eligibility Criteria

Inclusion

Inclusion criteria:

  1. Young adult e-cigarette user or older adult smoker

  2. Willing to abstain from all nicotine product use for 12 hours prior to the studyvisit

  3. Read and speak English

Exclusion

Exclusion criteria:

  1. Currently attempting to quit nicotine products

  2. Currently pregnant, planning to become pregnant, or breastfeeding

  3. Current or past use of tobacco products other than e-cigarettes or cigarettes

  4. Self-reported diagnosis of lung disease

  5. Self-reported new or unstable cardiovascular disease

Study Design

Total Participants: 150
Treatment Group(s): 10
Primary Treatment: Vaping study EC C
Phase:
Study Start date:
May 30, 2023
Estimated Completion Date:
February 26, 2024

Connect with a study center

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio 43210
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.